Patheon IncTSX: PTI

Patheon Issues Statement in Response to Recent Trading Activity

· Issued by Patheon Inc via CNW
Website: www.patheon.com

TORONTO, Nov. 16 /CNW/ - Patheon Inc. (TSX: PTI) today issued the
following statement in response to recent trading activity. As previously
announced on September 11, 2006, the Board of Patheon has established a
special committee and engaged financial advisors to evaluate strategic and
financial alternatives for the company. The company is in discussions with a
number of parties with regard to various alternatives. There can be no
assurance that a transaction or other material development will result from
this process. No further announcements will be made by the company unless and
until circumstances so warrant.

Patheon (TSX:PTI; www.patheon.com) is a leading global provider of drug
development and manufacturing services to the international pharmaceutical
industry. Patheon operates a network of 14 facilities in the United States,
Canada and Europe, employing more than 5,900 people and serving a client base
of more than 200 pharmaceutical and biotechnology companies.

%SEDAR: 00001700E

Patheon Inc on 6ix

Story so far

Earlier from Patheon

Later from Patheon

All Patheon news releases